Key result
PCI matches CABG for 5-year major events in low or intermediate complexity left main disease.
Why the study?
Does PCI reduce the composite outcome of death, stroke, or myocardial infarction at 5 years compared to CABG in patients with left main coronary artery disease of low or intermediate anatomical complexity?
Does PCI reduce the composite outcome of death, stroke, or myocardial infarction at 5 years compared to CABG in patients with left main coronary artery disease of low or intermediate anatomical complexity?
In patients with low or intermediate complexity left main coronary artery disease, PCI is comparable to CABG for the composite outcome of death, stroke, or MI at 5 years.
Supports PCI as alternative to CABG in low- or intermediate-complexity left main disease; confirms comparable 5-year outcomes.
In patients with left main coronary artery disease of low or intermediate anatomical complexity, there was no significant difference between PCI and CABG with respect to the rate of the composite outcome of death, stroke, or myocardial infarction at 5 years. (Funded by Abbott Vascular; EXCEL ClinicalTrials.gov number, NCT01205776.).
No takes yet. Share an insight, caveat, or question.
Stone et al. (2019) studied this question. In patients with low or intermediate complexity left main coronary disease, PCI and CABG had similar 5-year rates of death, stroke, or myocardial infarction.